Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Diagnosis & Prognosis|April 11, 2022
Immune Checkpoint Inhibitor for Non-small Cell Lung Cancer With Negative or Low Tumor PD-L1 ExpressionMinehiko Inomata, Naoki Takata, Isami Mizushima, et al.
Scientific Reports|July 4, 2023
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancerMinehiko Inomata, Masahiro Matsumoto, Naoki Takata, et al.
In Vivo (Athens, Greece)|April 29, 2021
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint InhibitorsKana Hayashi, Kotaro Tokui, Minehiko Inomata, et al.
Anticancer Research|February 29, 2024
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet ChemotherapyMinehiko Inomata, Shuhei Minatoyama, Naoki Takata, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Multicenter Retrospective Analysis of Pulmonary Sarcomatoid Carcinoma Clinically Diagnosed Using Small Biopsy SpecimensMinehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, et al.
Frontiers in Plant Science|April 14, 2025
Effects of <i>feruloyl-CoA 6'-hydroxylase 1</i> overexpression on lignin and cell wall characteristics in transgenic hybrid aspenNaning Wang, Masatsugu Takada, Shingo Sakamoto, et al.
The Plant Journal : for Cell and Molecular Biology|January 19, 2022
Rerouting of the lignin biosynthetic pathway by inhibition of cytosolic shikimate recycling in transgenic hybrid aspenShi Hu, Naofumi Kamimura, Shingo Sakamoto, et al.
In Vivo (Athens, Greece)|April 30, 2024
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case ReportTakahiro Hirai, Minehiko Inomata, Shuhei Minatoyama, et al.
Npj Biological Timing and Sleep|April 10, 2025
Nature's Master of Ceremony: The <i>Populus</i> Circadian Clock as Orchestratot of Tree Growth and PhenologyBertold Mariën, Kathryn M Robinson, Manuela Jurca, et al.
Pageof 8